The Osteoclast in Bone Metastasis: Player and Target.

Area of Science:

• Oncology
• Bone Biology
• Cancer Metastasis

Background:

• Bone metastases are a frequent and devastating complication for breast and prostate cancer patients.
• Metastasis to bone is currently considered an incurable disease, posing significant challenges in treatment.
• The bone microenvironment supports tumor growth and is actively modulated by cancer cells.

Purpose of the Study:

• To review the role of osteoclasts in the "vicious cycle" of bone metastasis.
• To elucidate how tumor cells influence osteoclast formation and activity.
• To discuss current and emerging therapeutic strategies for bone metastases.

Main Methods:

• Literature review focusing on the interaction between tumor cells and bone cells.
• Analysis of the mechanisms driving osteoclast activation in the bone metastatic niche.
• Examination of therapeutic targets within the tumor-bone microenvironment.

Main Results:

• Tumor cells actively perturb the bone microenvironment, promoting osteoclastogenesis and activity.
• Osteoclasts are key mediators in the "vicious cycle" that promotes tumor proliferation and bone deregulation.
• Targeting the tumor cell-osteoclast network offers a promising therapeutic avenue.

Conclusions:

• Understanding the intricate interplay between tumor cells and osteoclasts is crucial for developing effective bone metastasis treatments.
• Current antiresorptive drugs and novel targeted therapies show potential in managing bone metastases.
• Further research into targeting this complex network could lead to improved patient outcomes.